...
首页> 外文期刊>Radiation oncology >Influence of 68 Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: differential impact of photon and proton radiotherapy
【24h】

Influence of 68 Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: differential impact of photon and proton radiotherapy

机译:68 Ga-DOTATOC对颅底脑膜瘤放射治疗的正常组织保留的影响:光子和质子放射治疗的不同影响

获取原文

摘要

To evaluate the impact of 68Ga-DOTATOC-PET on treatment planning and sparing of normal tissue in the treatment of skull base meningioma with advanced photons and protons. From the institutional database consisting of 507 skull base meningiomas 10 patients were chosen randomly for the present analysis. Target volume definition was performed based on CT and MRI only, as well as with additional 68Ga-DOTATOC-PET. Treatment plans were performed for Intensity Modulated Radiotherapy (IMRT) and proton therapy using active raster scanning on both target volumes. We calculated doses to relevant organs at risk (OAR), conformity indices as well as differences in normal tissue sparing between both radiation modalities based on CT/MRI planning as well as CT/MRI/PET planning. For photon treatment plans, PET-based treatment plans showed a reduction of brain stem Dmax and Dmedian for different levels of total dose. At the optic chiasm, use of 68Ga-DOTATOC significantly reduces Dmax; moreover, the Dmedian is reduced in most cases, too. For both right and left optic nerve, reduction of dose by addition of 68Ga-DOTATOC-PET is minimal and depends on the anatomical location of the meningioma. In protons, the impact of 68Ga-DOTATOC-PET is minimal compared to photons. Addition of 68Ga-DOTATOC-PET information into treatment planning for skull base meningiomas has a significant impact on target volumes. In most cases, PET-planning leads to significant reductions of the treatment volumes. Subsequently, reduced doses are applied to OAR. Using protons, the benefit of additional PET is smaller since target coverage?is more conformal and?dose to OAR is already reduced compared to photons. Therefore, PET-imaging has the greatest margin of benefit in advanced photon techniques, and combination of PET-planning and high-precision treatment leads to comparable treatment plans as with protons.
机译:评估68Ga-DOTATOC-PET对晚期光子和质子的颅底脑膜瘤的治疗计划和正常组织保留的影响。从包括507个颅底脑膜瘤的机构数据库中随机选择10例患者进行本次分析。仅基于CT和MRI以及其他68Ga-DOTATOC-PET进行目标体积定义。使用主动光栅扫描对两个目标体积进行了调强放疗(IMRT)和质子治疗的治疗计划。我们基于CT / MRI计划以及CT / MRI / PET计划,计算了相关风险器官(OAR)的剂量,合格指数以及两种放射方式之间正常组织备用的差异。对于光子治疗计划,基于PET的治疗计划显示不同总剂量水平的脑干Dmax和Dmedian降低。在视交叉方面,使用68Ga-DOTATOC可显着降低Dmax。此外,在大多数情况下,Dmedian也会减少。对于左右视神经,通过添加68Ga-DOTATOC-PET来减少剂量是最小的,这取决于脑膜瘤的解剖位置。在质子中,与光子相比,68Ga-DOTATOC-PET的影响极小。将68Ga-DOTATOC-PET信息添加到颅底脑膜瘤的治疗计划中对目标量有重大影响。在大多数情况下,PET计划可显着减少治疗量。随后,将减少的剂量应用于OAR。使用质子,额外的PET的益处较小,因为与光子相比,目标覆盖范围更加保形,并且OAR的剂量已经减少。因此,PET成像在先进的光子技术中具有最大的优势,并且PET计划与高精度治疗相结合可产生与质子相当的治疗计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号